Fort Point Capital Partners LLC Pfizer Inc Transaction History

Fort Point Capital Partners LLC

$786 Million
Q2 2024

A detailed history of Fort Point Capital Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 9,061 shares of PFE stock, worth $237,760. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,061

Previous 8,627 5.03%

Holding current value

$237,760

Previous $239,000 5.86%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $10,962 - $12,846	434 Added 5.03%	9,061 $253,000
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $223,353 - $256,480	8,627 New	8,627 $239,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $20,010 - $23,151	-554 Reduced 5.27%	9,955 $365,000
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $43,604 - $56,766	-1,107 Reduced 9.53%	10,509 $428,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $83,500 - $109,000	-2,000 Reduced 14.69%	11,616 $595,000
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $126,510 - $154,437	2,891 Added 26.96%	13,616 $596,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $7,537 - $8,937	162 Added 1.53%	10,725 $562,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $71,964 - $89,173	1,573 Added 17.5%	10,563 $547,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $28,103 - $36,100	-716 Reduced 7.38%	8,990 $387,000
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $8,977 - $10,170	250 Added 2.64%	9,706 $380,000
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $316,681 - $357,153	9,456 New	9,456 $343,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $150,070 - $214,418	-5,552 Closed	0 $0
Q4 2019 Feb 03, 2020	SELL	$32.92 - $37.36 $6,584 - $7,472	-200 Reduced 3.48%	5,552 $218,000
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $186,882 - $242,331	5,752 New	5,752 $207,000
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $473,887 - $520,644	-12,637 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $1,808 - $2,061	-47 Reduced 0.37%	12,637 $552,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $100,273 - $121,625	2,909 Added 29.76%	12,684 $559,000
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $117,969 - $125,767	-3,577 Reduced 26.79%	9,775 $355,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $24,730 - $28,690	775 Added 6.16%	13,352 $474,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $205,214 - $217,739	6,170 Added 96.3%	12,577 $456,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $198,617 - $218,799	6,407	6,407 $229,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.

Account

Fort Point Capital Partners LLC Pfizer Inc Transaction History